涪陵榨菜(002507.SZ)业绩快报:2020年度净利润升28.42%至7.77亿元
格隆汇2月26日丨涪陵榨菜(002507.SZ)披露2020年度业绩快报,实现营业总收入22.73亿元,同比增长14.23%;营业利润9.15亿元,同比增长27.28%;利润总额9.14亿元,同比增长28.32%;归属于上市公司股东的净利润7.77亿元,同比增长28.42%;基本每股收益0.98元。
报告期内,面对新冠肺炎疫情和严峻复杂的国内外经济形势,公司紧紧围绕“适应变化,主动改变,突破发展”的战略目标,带领全体员工攻坚克难,积极采取多种措施,全面协同开展销售、生产、供应、项目发展、管理等核心业务工作,保持了公司业绩的稳定增长,为公司后续发展打下扎实的基础。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.